Clin2
NCT05756244Possibly a fitRecruiting

Managing blood thinners during pregnancy to prevent clot problems

Pregnancy RelatedVenous Thromboembolism

Part of Heart & circulation clinical trials.

This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
825 people
Ages
18 years to 60 years
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You need blood thinners during pregnancy (before delivery) for a clot-related reason
  • Your reason includes a confirmed blood clot (during this pregnancy or another), or a blood-clotting condition (thrombophilia) that needs treatment
  • You are currently taking LMWH during pregnancy (any dose or type)
  • You plan to deliver in a hospital setting, not at home or a birthing center
  • You can give consent to join the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06494878Recruiting· Phase 3
Aspirin after childbirth to prevent blood clots

This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.

Brussels
NCT05735639Recruiting· Phase 4
Prevention of blood clots during varicose vein treatment

This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.

London
NCT06531525Not yet recruiting· Phase 2
Low molecular weight heparin for protein S deficiency in pregnancy

This trial tests whether a blood-thinning medicine (low molecular weight heparin) can improve pregnancy outcomes in women with protein S deficiency, a condition that raises the risk of blood clots. The goal is to see if this treatment helps prevent pregnancy complications caused by clots.

Beijing, Beijing/Beijing
NCT06575309Recruiting
Blood clotting in pregnancy and the effect of blood thinner

This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.

Clermont-Ferrand
NCT07658989Recruiting
Blood thinners in pregnancy with mechanical heart valves

This study looks at the best way to manage blood thinners for pregnant people who have mechanical heart valves. It aims to find the safest approach for both the mother and the baby.

Toronto, Ontario
NCT03659708Recruiting
Study to prevent dangerous blood clots during pregnancy

This study looks at pregnancy-related risk for a dangerous blood clot in the leg or lung (venous thromboembolism). It focuses on pregnant people who already have a higher-than-average risk and wants to see how to manage that risk safely.

Bron

Hear when a new Pregnancy Related trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.